The DDL Conference, taking place in Edinburgh, Scotland, attracts over 1,000 global experts annually, including scientists, clinicians, and industry leaders. Belhaven Biopharma will present these ...
A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...
The proceeds of the Transaction are expected to result in a total cumulative gross amount of at least EUR 7 million in immediate new funding for the Company. The Company could receive further proceeds ...
PORTLAND, IA, UNITED STATES, December 9, 2024 /EINPresswire / -- Growth of the novel vaccine delivery system market is driven by rise in immunization programs & their increasing coverage, increasing ...